de Boer Jaap, Jager Pieter L, Wiggers Theo, Nieboer Peter, Machteld Wymenga A N, Pras Elisabeth, Hoogenberg Klaas, Sleijfer Dirk T, Suurmeijer Albert J H, van der Graaf Winette T A
Department of Medical Oncology, University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Int J Clin Oncol. 2006 Dec;11(6):478-81. doi: 10.1007/s10147-006-0606-1. Epub 2006 Dec 25.
We report a patient with a nonresectable histologically benign solitary fibrous tumor who suffered from paraneoplastic non-islet cell tumor hypoglycemia (NICTH). Diagnostic workup revealed malignant characteristics in which the tumor showed up as, presumably, false-negative on fluorodeoxyglucose-positron emission tomography (FDG-PET), while being positive on tyrosine-PET. Neoadjuvant treatment, which consisted of combined chemo-radiation and consecutive selective embolization of the tumor feeding vessels, caused such a therapeutic effect, on both NICTH and reduction in tumor volume, that a secondary resection, with the patient in a normoglycemic status, was possible. Our report highlights several important issues in the management of the patient with a nonresectable solitary fibrous tumor with severe episodes of hypoglycemia due to NICTH.
我们报告了一例组织学上为良性的不可切除性孤立性纤维瘤患者,该患者患有副肿瘤性非胰岛细胞瘤低血糖症(NICTH)。诊断性检查发现了恶性特征,即该肿瘤在氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)上可能显示为假阴性,而在酪氨酸-PET上呈阳性。新辅助治疗包括联合放化疗以及随后对肿瘤供血血管进行选择性栓塞,对NICTH和肿瘤体积缩小均产生了治疗效果,使得在患者血糖正常的情况下能够进行二次切除。我们的报告强调了在管理因NICTH导致严重低血糖发作的不可切除性孤立性纤维瘤患者时的几个重要问题。